New investigational targeted therapeutic, entrectinib, shows early promise

Paediatric and adult high grade gliomas: A tale of a histone tail

Galectins in tumour immunity

Multiplex IHC as biomarkers for cancer immunotherapy

Integrating multiple omics information in the era of precision oncology

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer

Breast cancer risk prediction models improved by adding multiple biological markers of risk

Mechanisms of immune escape in non-Hodgkin lymphoma

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

Technologies for personalised cancer immunotherapies

Chronic lymphocytic leukaemia: Transition to a new era

p62: Metabolism and the tumour microenvironment